Figure 2: Sales growth of the top five osteoporosis products ... of calcitonin (see Table 1 for overview of late-stage compounds). The global osteoporosis market was valued at US$9.2 billion ...

Osteoporosis is characterized by weak ... Indeed, in August, Lilly stopped the development of its late-stage SERM arzoxifene after a 5-year Phase III trial met its primary end points but failed ...

Symptoms of osteoporosis can be silent in the early stages, as you may not have any obvious signs of the condition ... In general, women often break bones between 5 to 10 years earlier than their male ...